UNSPSC 51285003: Piperacillin/tazobactam

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM113. This VA Drug Class (AM113) classifies this compound as belonging to the group EXTENDED SPECTRUM PENICILLINS.

UNSPSC 51285003 Piperacillin/tazobactam is a Commodity code that captures pharmaceutical procurement by state and local health agencies, though recent activity shows limited direct solicitation under this specific antibiotic SKU. Instead, state and local health departments and county health systems are using piggyback and cooperative purchasing vehicles to acquire individual pharmaceutical products through pharmaceutical distributors and third-party logistics providers. The work being solicited involves the supply and warehousing of branded and generic pharmaceuticals — in recent cases, antibiotics like doxycycline and ciprofloxacin, as well as naloxone and drug deactivation systems — delivered on fixed contracts with defined terms, renewal options, and quarterly or as-needed fulfillment schedules. Issuing bodies include state departments of public health, county health departments, and county community health agencies procuring through competitive bid processes (IFB and ITB) or piggyback awards under existing statewide cooperative purchasing agreements such as MMCAP Infuse.

Recent activity appears concentrated in Illinois and Florida, with the Illinois Department of Public Health awarding a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026 (award completed, not an open solicitation) for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets with a 12-month initial term and two renewal options, and Seminole County, Florida issuing an IFB (IFB60459723LAS, due July 26, 2023, but posted June 30, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. Both procurements emphasize competitive pricing, vendor qualifications including drug-free workplace certification and E-Verify compliance, and fixed-fee or unit-cost structures. The code shows limited recent open-market activity under the specific piperacillin/tazobactam SKU itself; most pharmaceutical procurement at state and local level flows through cooperative purchasing agreements and existing vendor contracts rather than new commodity-level solicitations.